Empagliflozin confers kidney-protective benefits after acute MI
By
Haymarket Media
Sep 09, 2024
A reduced risk was seen for total hospitalizations for heart failure, total adverse events of heart failure or all-cause mortality.
Mental health treatment linked to better outcomes in CAD, heart failure
Mar 22, 2024
Patients receiving mental health treatment were less likely to be rehospitalized, have an emergency department visit or die from any cause.
Triglyceride-glucose index independently linked to all-cause mortality
Jun 21, 2024
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
Up to 30 percent of CVD mortality attributable to excess salt intake
Mar 29, 2024
The population-attributable risk estimates suggest that sodium above the recommended intake is linked to 10 to 30% of CVD mortality.
Gains in heart failure mortality have been erased
Apr 26, 2024
The declines seen in heart failure mortality rates from 1999 to 2012 were reversed from 2012 to 2021.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
Menopausal hormone therapy use beyond 65 years beneficial
Apr 16, 2024
Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April...
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.